United States · FDA National Drug Code directory
Clindamycin hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85534-0087_56dce2d7-c4ea-2e79-e063-6394a90af558
- Product NDC
- 85534-0087
- Form
- CAPSULE
- Composition / generic term
- Clindamycin hydrochloride
- Labeler
- HAWAII REPACK, INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20010323
- Source listing expiry
- 20271231
Source-listed ingredients
- CLINDAMYCIN HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 8 CAPSULE in 1 BOTTLE (85534-0087-0) · 85534-0087-0
- 12 CAPSULE in 1 BOTTLE (85534-0087-1) · 85534-0087-1
- 20 CAPSULE in 1 BOTTLE (85534-0087-2) · 85534-0087-2
- 28 CAPSULE in 1 BOTTLE (85534-0087-3) · 85534-0087-3
- 30 CAPSULE in 1 BOTTLE (85534-0087-4) · 85534-0087-4
- 40 CAPSULE in 1 BOTTLE (85534-0087-5) · 85534-0087-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →